OviTex® Core F10254-2020GRecalls & reported problems
Aroa Biosurgery Limited · The OviTex® Reinforced Tissue Matrix Device is a sterile reinforced matrix device comprised of non-dermal sourced layers of extracellular matrix (ECM) (ovine (sheep) derived ECM), paired with a minimal suture footprint. OviTex Reinforced Tissue Matrix Device provides an alternative device solution to permanent synthetic, resorbable/bioabsorbable synthetic, and biologic meshes. The device remodels and helps regenerate tissue while reinforcing the repair and providing structural support. Reinforced tissue matrices enhance performance while maintaining compatibility with the body. The OviTex Reinforced Tissue Matrix Device is used for hernia repair and abdominal wall reconstruction. · Class 2 · Implant
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 09421904065277), received between Dec 21, 2018 and Dec 14, 2021 — classified as 3 injuries.
The most frequently reported specific device problem is “Insufficient Device Problem Information” (1 report).
21 other recalls cover devices cleared under the same FDA submission (K153633); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Insufficient Device Problem Information1
Patient problems
- Seroma2
- No Code Available1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryDec 14, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT A PATIENT EXPERIENCED A PERSISTENT SEROMA AFTER IMPLANTATION OF OVITEX R TO REINFORCE A DIEP FLAP DONOR SITE ON (B)(6) 2021. THE IMPLANTED MATERIAL WAS PARTIALLY REMOVED ON (B)(6) 2021.
Patient problems: Seroma
MAUDE report 13003967 ↗InjuryDec 14, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT A PATIENT EXPERIENCED A PERSISTENT SEROMA AFTER IMPLANTATION OF OVITEX R TO REINFORCE A DIEP FLAP DONOR SITE ON (B)(6) 2021. THE IMPLANTED MATERIAL WAS PARTIALLY REMOVED ON (B)(6) 2021.
Patient problems: Seroma
MAUDE report 13001805 ↗InjuryDec 21, 2018Insufficient Device Problem Information; Insufficient Device Problem Information
A PATIENT REPORTED THAT SHE UNDERWENT BILATERAL BREAST RECONSTRUCTION IN WHICH OVITEX WAS UTILIZED. SHE REPORTED THAT SOMETIME AFTER THE PROCEDURE THAT SHE BELIEVED THAT THE MESH DID NOT STAY IN PLACE IN ONE BREAST AND THE IMPLANT "ALMOST LITERALLY FELL OUT". THE BREAST IMPLANT ENDED UP BEING SURGICALLY REMOVED.
Patient problems: No Code Available
MAUDE report 8190303 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K153633. One submission often covers many models, so check the product and lot details in each record.
- Z-0430-2019 · Apr 6, 2018 · TerminatedOviTex 2S Reinforced BioScaffold 10x20cm, Part Number F10258-1020G
- Z-0435-2019 · Apr 6, 2018 · TerminatedOviTex 2S Reinforced BioScaffold 10x12cm, Part Number F10258-1012G
- Z-0432-2019 · Apr 6, 2018 · TerminatedOviTex 2S Reinforced BioScaffold 18x22cm, Part Number F10258-1822G
- Z-0429-2019 · Apr 6, 2018 · TerminatedOviTex 2S Reinforced BioScaffold 10x12cm, Part Number F10258-1012G
- Z-0422-2019 · Apr 6, 2018 · TerminatedOviTex 1S Reinforced BioScaffold 6x10cm, Part Number F10256-0610G
- Z-0419-2019 · Apr 6, 2018 · TerminatedOviTex Reinforced BioScaffold 16x20cm, Part Number F10254-1620G
- Z-0434-2019 · Apr 6, 2018 · TerminatedOviTex Reinforced BioScaffold 18x22cm, Part Number F10254-1822G
- Z-0426-2019 · Apr 6, 2018 · TerminatedOviTex 1S Reinforced BioScaffold 18x22cm, Part Number F10256-1822G
- Z-0418-2019 · Apr 6, 2018 · TerminatedOviTex Reinforced BioScaffold 10x20cm, Part Number F10254-1020G
- Z-0421-2019 · Apr 6, 2018 · TerminatedOviTex 1S Reinforced BioScaffold 4x8cm, Part Number F10256-0408G
- Z-0417-2019 · Apr 6, 2018 · TerminatedOviTex Reinforced BioScaffold 10x12cm, Part Number F10254-1012G
- Z-0427-2019 · Apr 6, 2018 · TerminatedOviTex 1S Reinforced BioScaffold 20x20cm, Part Number F10256-2020G
- Z-0416-2019 · Apr 6, 2018 · TerminatedOviTex Reinforced BioScaffold 6x10cm, Part Number F10254-0610G
- Z-0423-2019 · Apr 6, 2018 · TerminatedOviTex 1S Reinforced BioScaffold 10x12cm, Part Number F10256-1012G
- Z-0420-2019 · Apr 6, 2018 · TerminatedOviTex Reinforced BioScaffold 20x20cm, Part Number F10254-2020G
…and 6 more.
Other Mesh, Surgical devices
- MEDPOR TITAN 81032Stryker Leibinger GmbH & Co. KG · Mesh, surgical1 recall1 report
- Peri-Guard PC1016NSynovis Life Technologies, Inc. · Mesh, surgical1 recall1 report
- SurgiMend® 606-200-020Tei Biosciences Inc. · Mesh, surgical1 recall0 reports
- SurgiMend® 606-005-001Tei Biosciences Inc. · Mesh, surgical1 recall0 reports
- SurgiMend® 606-300-008Tei Biosciences Inc. · Mesh, surgical1 recall0 reports
- SurgiMend® 606-200-016Tei Biosciences Inc. · Mesh, surgical1 recall0 reports
- SurgiMend® 606-300-021Tei Biosciences Inc. · Mesh, surgical1 recall0 reports
- SurgiMend® 606-206-007Tei Biosciences Inc. · Mesh, surgical1 recall0 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page